HB 320 DE

0likes☆Favorite🔕SubscribeShare

Became Law

In 2000, the United States Federal Drug Administration ("FDA") first approved the Risk Evaluation and Mitigation Strategy ("REMS") for Mifeprex; and approved the generic version of Mifeprex, Mifepristone, in 2019. A regimen approved by the FDA in 2016 for Mifeprex and Mifepristone includes the use of Misoprostol. Under the REMS approved by the FDA, healthcare providers who wish to prescribe Mifepristone, Misoprostol, or Mifeprex must complete a Prescriber Agreement before ordering and dispensing the medication. Physicians assistants and advanced practiced registered nurses (APRNs) are healthcare providers who are eligible to prescribe these medications under the REMS. This bill allows physician assistants and advanced practice registered nurses to prescribe medication for the termination of pregnancy including Mifeprex, Mifepristone, and Misoprostol.

• Debra Heffernan Democratic · primary
• Kyle Evans Gay · primary
• Bryan Townsend Democratic · primary
• Laura V. Sturgeon Democratic · primary
• Valerie Longhurst · primary
• Melissa Minor-Brown Democratic · primary
• Sherry Dorsey Walker · primary
• Sarah McBride · primary

1. Mar 9, 2022 Introduced and Assigned to Health & Human Development Committee in House · lower
2. Mar 16, 2022 Reported Out of Committee (Health & Human Development) in House with 5 Favorable, 3 On Its Merits · lower
3. Mar 24, 2022 Passed By House. Votes: 25 YES 15 NO 1 ABSENT · lower
4. Mar 24, 2022 Assigned to Health & Social Services Committee in Senate · upper
5. Mar 31, 2022 Re-Assigned to Legislative Oversight & Sunset Committee in Senate · upper
6. Apr 5, 2022 Reported Out of Committee (Legislative Oversight & Sunset) in Senate with 3 Favorable · upper
7. Apr 7, 2022 Passed By Senate. Votes: 14 YES 7 NO · upper
8. Apr 28, 2022 Signed by Governor · executive